title: FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations.
abstract: Internal tandem duplications of the FMS-like tyrosine kinase 3 (FLT3) gene are one of the most frequent gene mutations in acute myeloid leukemia (AML) and are associated with poor clinical outcome. The remission rate is high with intensive chemotherapy, but most patients eventually relapse. During the last decade, FLT3 mutations have emerged as an attractive target for a molecularly specific treatment strategy. Targeting FLT3 receptor tyrosine kinases in AML has shown encouraging results in the treatment of FLT3 mutated AML, but in most patients responses are incomplete and not sustained. Newer, more specific compounds seem to have a higher potency and selectivity against FLT3. During therapy with FLT3 tyrosine kinase inhibitors (TKIs) the induction of acquired resistance has emerged as a clinical problem. Therefore, optimization of the targeted therapy and potential treatment options to overcome resistance is currently the focus of clinical research. In this review we discuss the use and limitations of TKIs as a therapeutic strategy for the treatment of FLT3 mutated AML, including mechanisms of resistance to TKIs as well as possible novel strategies to improve FLT3 inhibitor therapy.
authors: Department of Internal Medicine III, University Hospital of Ulm , Germany.
authors: Sabine
authors: S
authors: Kayser
authors: Mark J
authors: MJ
authors: Levis
mesh_terms: D000208:Acute Disease; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D009364:Neoplasm Recurrence, Local; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D020080:Tandem Repeat Sequences / Q000235:genetics; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
chemical_list: D047428:Protein Kinase Inhibitors; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3
references: Leukemia. 2006 Nov;20(11):2074-6
references: 16990788
references: Blood. 2006 May 1;107(9):3700-7
references: 16410449
references: J Clin Oncol. 2011 Feb 10;29(5):475-86
references: 21220609
references: Biol Blood Marrow Transplant. 2011 Sep;17(9):1404-9
references: 21324374
references: Blood. 2005 Jun 15;105(12):4792-9
references: 15718420
references: Blood. 2005 Dec 1;106(12):3768-76
references: 16105978
references: Hematology Am Soc Hematol Educ Program. 2011;2011:121-7
references: 22160023
references: Blood. 2004 Aug 15;104(4):1145-50
references: 15126317
references: Blood. 2009 Jun 25;113(26):6567-71
references: 19389879
references: Leukemia. 2010 Aug;24(8):1437-44
references: 20535150
references: Blood. 2005 Jul 1;106(1):265-73
references: 15769897
references: Cancer Cell. 2009 Nov 6;16(5):401-12
references: 19878872
references: J Clin Oncol. 2010 Apr 10;28(11):1856-62
references: 20212254
references: Br J Haematol. 2012 May;157(4):483-92
references: 22409268
references: Cancer. 2012 Dec 1;118(23):5819-22
references: 22605576
references: Leukemia. 2013 Jan;27(1):48-55
references: 22858906
references: Blood. 2000 Dec 1;96(12):3907-14
references: 11090077
references: Cell. 2012 Jul 20;150(2):264-78
references: 22817890
references: Annu Rev Genomics Hum Genet. 2002;3:179-98
references: 12194988
references: Blood. 2006 Nov 15;108(10):3262-70
references: 16857985
references: Blood. 2010 Jan 21;115(3):453-74
references: 19880497
references: Blood. 2010 Feb 18;115(7):1425-32
references: 20007803
references: Blood. 2005 Feb 1;105(3):986-93
references: 15459012
references: Blood. 2011 Mar 24;117(12):3286-93
references: 21263155
references: Leukemia. 2012 Sep;26(9):2061-8
references: 22627678
references: Blood. 2004 May 15;103(10):3669-76
references: 14726387
references: Cancer Res. 2005 Nov 1;65(21):9643-50
references: 16266983
references: Blood. 2001 Apr 15;97(8):2434-9
references: 11290608
references: Biol Blood Marrow Transplant. 2011 Dec;17(12):1874-7
references: 21767516
references: N Engl J Med. 2012 Mar 22;366(12):1079-89
references: 22417203
references: Cancer Res. 2009 Apr 1;69(7):3032-41
references: 19318574
references: Blood. 2013 Apr 4;121(14):2734-8
references: 23377436
references: Blood. 2007 Mar 1;109(5):2264-5; author reply 2265
references: 17312001
references: Am J Clin Pathol. 2004 Sep;122(3):348-58
references: 15362364
references: Oncogene. 2000 Feb 3;19(5):624-31
references: 10698507
references: Leukemia. 1996 Dec;10(12):1911-8
references: 8946930
references: Blood. 2006 Jan 1;107(1):293-300
references: 16150941
references: Blood. 2007 Feb 15;109(4):1643-52
references: 17047150
references: Nature. 2012 Apr 15;485(7397):260-3
references: 22504184
references: Blood. 2006 Nov 15;108(10):3477-83
references: 16857987
references: Blood. 2009 Oct 1;114(14):2984-92
references: 19654408
references: Blood. 2006 May 1;107(9):3724-6
references: 16368883
references: Leukemia. 2012 Nov;26(11):2353-9
references: 22504140
references: Clin Cancer Res. 2003 Nov 15;9(15):5465-76
references: 14654525
references: J Clin Oncol. 2012 Mar 1;30(7):735-41
references: 22291086
references: Blood. 2005 Jan 1;105(1):54-60
references: 15345597
references: J Clin Oncol. 2010 Oct 1;28(28):4339-45
references: 20733134
references: Leukemia. 2006 Dec;20(12):2130-6
references: 17066094
references: Blood. 2002 Dec 15;100(13):4372-80
references: 12393388
references: Cancer Res. 2001 Oct 1;61(19):7233-9
references: 11585760
references: Blood. 2006 Dec 1;108(12):3674-81
references: 16902153
references: Blood. 2013 Apr 18;121(16):3165-71
references: 23430109
references: N Engl J Med. 2008 May 1;358(18):1909-18
references: 18450602
references: Blood. 2008 Mar 1;111(5):2776-84
references: 17957027
references: Blood. 2011 Mar 24;117(12):3294-301
references: 21270442
references: Blood Rev. 2004 Jun;18(2):115-36
references: 15010150
references: J Natl Cancer Inst. 2008 Feb 6;100(3):184-98
references: 18230792
references: Blood. 2009 Apr 23;113(17):4074-7
references: 18483393
references: Blood. 2002 Sep 1;100(5):1532-42
references: 12176867
references: Blood. 2006 Jul 1;108(1):405-6; author reply 406
references: 16790588
references: N Engl J Med. 2009 Sep 10;361(11):1058-66
references: 19657110
references: Bone Marrow Transplant. 2012 Jan;47(1):137-8
references: 21423122
references: Br J Haematol. 2001 Jun;113(4):983-8
references: 11442493
references: Blood. 2009 Sep 17;114(12):2386-92
references: 19602710
references: Genes Chromosomes Cancer. 2012 Oct;51(10):910-24
references: 22674490
references: Blood. 2009 Apr 23;113(17):4052-62
references: 19144991
references: Biol Blood Marrow Transplant. 2012 Dec;18(12):1845-50
references: 22766221
references: Blood. 2008 May 15;111(10):4930-3
references: 18305215
references: Semin Hematol. 2008 Jul;45(3 Suppl 2):S17-21
references: 18760705
references: Leukemia. 1997 Oct;11(10):1605-9
references: 9324277
references: Cancer Res. 2011 Jul 1;71(13):4696-706
references: 21546568
references: Blood. 2005 Nov 15;106(10):3658-65
references: 16076872
references: Leukemia. 2012 Oct;26(10):2233-44
references: 22469781
references: Leukemia. 2011 Aug;25(8):1297-304
references: 21537333
references: Blood. 2010 Dec 9;116(24):5089-102
references: 20705759
references: Neoplasma. 2007;54(1):89-94
references: 17233551
references: Bone Marrow Transplant. 2012 Dec;47(12):1535-7
references: 22659680
references: Blood. 2002 Jun 15;99(12):4326-35
references: 12036858
references: J Clin Oncol. 2006 Jan 1;24(1):25-35
references: 16314617
references: Nature. 2012 Jan 11;481(7382):506-10
references: 22237025
references: Blood. 2009 Apr 23;113(17):4063-73
references: 19144992